Syneos Health invests in Microsoft/Indegene platformBiopharma services company Syneos Health has taken a minority stake in Indegene Omnipresence, a partnership between life sciences Share XSyneos Health invests in Microsoft/Indegene platformhttps://pharmaphorum.com/news/syneos-health-microsoft-indegene-life-sciences-platform/
Boosting trial recruitment through patient engagementImproving clinical trial recruitment has long been a priority for pharma, but despite having a plethora of new Share XBoosting trial recruitment through patient engagementhttps://deep-dive.pharmaphorum.com/magazine/patient-engagement/boosting-trial-recruitment-through-patient-engagement-syneos/
15 pharma trends for 2020Real world evidence, patient centricity and new digital experiences are among the top 15 trends set to change Share X15 pharma trends for 2020https://pharmaphorum.com/views-analysis-digital/15-pharma-trends-for-2020/
Finding the right value propositionWith health technology assessment organisations becoming more powerful in Europe, and huge public scrutiny on drug prices in Share XFinding the right value propositionhttps://deep-dive.pharmaphorum.com/magazine/sales-and-marketing-2019/finding-the-right-value-proposition-syneos-health/
Join the dots or lose out, Syneos Health advises big pharmaPharma companies need to rethink how they communicate and share information and insights within their own organisations, according Share XJoin the dots or lose out, Syneos Health advises big pharmahttps://pharmaphorum.com/views-analysis-sales-marketing/join-the-dots-or-lose-out-syneos-health-advises-big-pharma/
eyeforpharma barcelona day twoDay two: Wednesday 13 March Highlights include: John Zibert, chief medical officer of LEO Innovation Lab, on being Share Xeyeforpharma barcelona day twohttps://pharmaphorum.com/views-and-analysis/eyeforpharma-barcelona-day-two/
eyeforpharma Barcelona day oneDay one: Tuesday 12 March Highlights include: Brent Saunders, CEO of Allergan, discusses the biggest challenges for the Share Xeyeforpharma Barcelona day onehttps://pharmaphorum.com/event-coverage/eyeforpharma-barcelona-2019-day-1/
Pharma in the age of accelerationSyneos Health tracks the future paths for healthcare technology to identify what will be truly disruptive for the Share XPharma in the age of accelerationhttps://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/pharma-in-the-age-of-acceleration/
The end of siloed healthcareFor the past eight years Syneos Health has been issuing annual healthcare trends forecasts, usually separated into Communications Share XThe end of siloed healthcarehttps://pharmaphorum.com/views-analysis-sales-marketing/the-end-of-siloed-healthcare/
